Gu P - Search Results

1

An Inducible CRISPR-dCas9-Based Transcriptional Repression System for Cancer Therapy.

Gu P, Zhao J, Zhang W, Ruan X, Hu L, Zeng Y, Hou X, Zheng X, Gao M, Chi J. Gu P, et al. Small Methods. 2024 Aug;8(8):e2301310. doi: 10.1002/smtd.202301310. Epub 2024 Jan 2. Small Methods. 2024. PMID: 38164884

2

Reduced MHC class II expression in medullary thyroid cancer identifies patients with poor prognosis.

Ruan X, Yi J, Hu L, Zhi J, Zeng Y, Hou X, Huang J, Gu P, Hao W, Gao M, Pan Y, Wei S, Zheng X. Ruan X, et al. Among authors: gu p. Endocr Relat Cancer. 2022 Jan 20;29(2):87-98. doi: 10.1530/ERC-21-0153. Endocr Relat Cancer. 2022. PMID: 34874277

3

KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway.

Zhang W, Ruan X, Li Y, Zhi J, Hu L, Hou X, Shi X, Wang X, Wang J, Ma W, Gu P, Zheng X, Gao M. Zhang W, et al. Among authors: gu p. Theranostics. 2022 Jan 3;12(4):1500-1517. doi: 10.7150/thno.66142. eCollection 2022. Theranostics. 2022. PMID: 35198054 Free PMC article.

4

Surgical selection and prognostic analysis in patients with unilateral sporadic medullary thyroid carcinoma.

Zhang J, Gu P, Huang D, Zhao J, Zheng X, Gao M. Zhang J, et al. Among authors: gu p. Langenbecks Arch Surg. 2022 Nov;407(7):3013-3023. doi: 10.1007/s00423-022-02591-9. Epub 2022 Jun 24. Langenbecks Arch Surg. 2022. PMID: 35748956

5

Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects.

Gu P, Ling B, Ma W, Zhang J, Zhang W, Zeng Y, Liu Y, Chi J, Ruan X, Zheng X, Wei S, Gao M. Gu P, et al. BMC Cancer. 2022 Nov 1;22(1):1116. doi: 10.1186/s12885-022-10173-7. BMC Cancer. 2022. PMID: 36319978 Free PMC article.

6

Characterization of the CpG island methylator phenotype subclass in papillary thyroid carcinoma.

Gu P, Zeng Y, Ma W, Zhang W, Liu Y, Guo F, Ruan X, Chi J, Zheng X, Gao M. Gu P, et al. Front Endocrinol (Lausanne). 2022 Oct 24;13:1008301. doi: 10.3389/fendo.2022.1008301. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36353231 Free PMC article.

7

Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer.

Hao W, Zhao J, Guo F, Gu P, Zhang J, Huang D, Ruan X, Zeng Y, Zheng X, Gao M. Hao W, et al. Among authors: gu p. PeerJ. 2023 Mar 13;11:e15025. doi: 10.7717/peerj.15025. eCollection 2023. PeerJ. 2023. PMID: 36935920 Free PMC article.

8

The survival outcomes of prophylactic lateral neck dissection for medullary thyroid carcinoma, a retrospective cohort study.

Hao W, Zhao J, Guo F, Zhang J, Gu P, Ruan X, Zhang W, Zheng X, Gao M. Hao W, et al. Among authors: gu p. Clin Otolaryngol. 2023 Sep;48(5):734-739. doi: 10.1111/coa.14053. Epub 2023 Jun 27. Clin Otolaryngol. 2023. PMID: 37366234

9

Analysis of Surgical Outcomes in Endoscopic-Assisted Lateral Neck Dissection.

Huang D, Zhao J, Gu P, Zhang J, Li Y, Zheng X. Huang D, et al. Among authors: gu p. Laryngoscope. 2024 May;134(5):2221-2227. doi: 10.1002/lary.31143. Epub 2023 Nov 8. Laryngoscope. 2024. PMID: 37937767

10

Changes of biochemical factors and the effect on recurrence of medullary thyroid carcinoma after surgery.

Guo F, Li L, Gu P, Zhang G, Ruan X, Zhao J, Zheng X, Wei S, Gao M. Guo F, et al. Among authors: gu p. Heliyon. 2024 Apr 17;10(8):e29857. doi: 10.1016/j.heliyon.2024.e29857. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38681571 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,484 results

Search Page

Filters